CHRISCIA BANE: Open Payments
NPI 1700416690 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,152 in 188 payments from 14 companies in 2025. Trend: 2023 $24,663 · 2024 $47,375 · 2025 $41,152
Speaker / faculty: $27,720Travel & lodging: $10,827Food & beverage: $2,523Education: $81
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 78 | $39,550 |
| Alkermes, Inc. | 33 | $391 |
| Teva Pharmaceuticals USA, Inc. | 15 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $207 |
| ABBVIE INC. | 14 | $196 |
| Vanda Pharmaceuticals Inc. | 10 | $158 |
| Neurocrine BioSciences, Inc. | 6 | $116 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $51 |
Products named: INVEGA SUSTENNA, ARISTADA, CAPLYTA, VRAYLAR, INGREZZA, FANAPT, UZEDY, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
